PDB11 Real-world cost-effectiveness of SGLT-2 inhibitors versus DPP-4 inhibitors for type 2 diabetes: A modeling study

Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.409
https://www.valueinhealthjournal.com/article/S1098-3015(21)00626-4/fulltext
Title : PDB11 Real-world cost-effectiveness of SGLT-2 inhibitors versus DPP-4 inhibitors for type 2 diabetes: A modeling study
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)00626-4&doi=10.1016/j.jval.2021.04.409
First page :
Section Title :
Open access? : No
Section Order : 10971
Categories :
Tags :
Regions :
ViH Article Tags :